?

Vogt Susan L N

Director
Anika Therapeutics, Inc.
US, Bedford [HQ]
CIK 1191270

Data Source

We automatically created this profile. The information was aggregated based on earnings call transcripts, insider forms and DEF 14A statements.

Latest Information

Shares :
23,778
Price per Share :
$16.19
Equivalence :
$384,965.82

Transaction History

  • 23,778 Shares After Transaction
    Value : $n/a
    $0.0
    06/08/22
  • Footnotes:
    #1 These shares represent restricted stock units. Each restricted stock unit represents a contingent right to receive one share of Anika Therapeutics, Inc. common stock. The restricted stock units vest in full on the earlier of the 2023 annual meeting of the Company's stockholders or June 8, 2023.
  • 30,278 Shares After Transaction
    Value : $n/a
    $0.0
    06/14/23
  • 36,049 Shares After Transaction
    Value : $n/a
    $0.0
    07/09/24
  • 43,065 Shares After Transaction
    Value : $n/a
    $0.0
    10/01/21
  • 43,065 Shares After Transaction
    Value : $376,818.75
    $376,818.75
    08/22/22

Get PRO Today.

PRO unlocks 1 more insider transactions made by Vogt Susan L N